To date, clinical data on CAR-T efficacy in CNSL are scarce, with only five studies reporting clinical outcomes of CAR-T for PCNSL/SCNSL, all using a CD19-CAR (Table 4). Here, CD19 is linked to primary central nervous system lymphoma.